SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 89 filers reported holding SPERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,000 | +171.4% | 19,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -93.8% | 19,000 | -26.9% | 0.00% | -100.0% |
| Q1 2022 | $226,000 | -81.2% | 26,000 | -65.3% | 0.00% | -80.0% |
| Q4 2021 | $1,201,000 | -38.2% | 75,000 | -28.9% | 0.02% | -44.4% |
| Q3 2021 | $1,942,000 | – | 105,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,932,209 | $76,246,000 | 15.85% |
| Atlas Venture Associates XI, LLC | 1,376,968 | $26,700,000 | 4.23% |
| Atlas Venture Associates IX, LLC | 1,376,968 | $26,700,000 | 4.23% |
| BVF INC/IL | 2,243,278 | $43,497,000 | 1.71% |
| AWM Investment Company, Inc. | 372,755 | $7,228,000 | 0.92% |
| Alphabet Inc. | 889,979 | $17,257,000 | 0.83% |
| Rock Springs Capital Management LP | 1,235,000 | $23,947,000 | 0.51% |
| Novo Holdings A/S | 576,702 | $11,182,000 | 0.48% |
| Artal Group S.A. | 500,000 | $9,695,000 | 0.21% |
| Granahan Investment Management | 420,320 | $8,150,000 | 0.18% |